ÀºÇòÅâÂÊ

ÀºÇòÅâÂÊ Services FAQ Contact Us 0
Home Healthcare IT Europe Autoimmune Disease Diagnostics Market Size , Growth to 2022-2030
Europe Autoimmune Disease Diagnostics Market
Select Regional / Country Report
Global Europe North America

Europe Autoimmune Disease Diagnostics Market Size, Share & Trends Analysis Report By Product (Consumables & Assay Kits, Instruments), By Test Type (Routine Laboratory Tests, Inflammatory Markers, Autoantibodies & Immunologic Test, Other Tests), By Disease (Rheumatoid Arthritis, Systemic Lupus Erythematosus, Sjögren’s Syndrome, Thyroiditis, Scleroderma, Other Diseases), By End User (Clinical Laboratories, Hospitals, Other End Users) and By Country(U.K., Germany, France, Spain, Italy, Russia, Nordic, Benelux, Rest of Europ) Forecasts, 2022-2030

Report Code: SRHI3271DR
Author : ÀºÇòÅâÂÊ
Buy Now
File Formats

Table Of Content

  1. Executive Summary
    1. Research Objectives
    2. Limitations & Assumptions
    3. Market Scope & Segmentation
    4. Currency & Pricing Considered
    1. Emerging Regions / Countries
    2. Emerging Companies
    3. Emerging Applications / End Use
    1. Drivers
    2. Market Warning Factors
    3. Latest Macro Economic Indicators
    4. Geopolitical Impact
    5. Technology Factors
    1. Porters Five Forces Analysis
    2. Value Chain Analysis
    1. Europe
  2. ESG Trends
    1. Introduction
    2. By Disease Type
      1. Introduction
        1. Disease Type By Value
      2. Systemic Autoimmune Disease
        1. By Value
        2. Rheumatoid Arthritis
          1. Rheumatoid Arthritis By Value
        3. Psoriasis
          1. Psoriasis By Value
        4. Systemic Lupus Erythematosus (SLE)
          1. Systemic Lupus Erythematosus (SLE) By Value
        5. Multiple Sclerosis
          1. Multiple Sclerosis By Value
        6. Ankylosing spondylitis
          1. Ankylosing spondylitis By Value
        7. Other Systemic Autoimmune Diseases
          1. Other Systemic Autoimmune Diseases By Value
      3. Localized Autoimmune Disease
        1. By Value
        2. Inflammatory Bowel Disease
          1. Inflammatory Bowel Disease By Value
        3. Type 1 Diabetes
          1. Type 1 Diabetes By Value
        4. Thyroid
          1. Thyroid By Value
        5. Multiple sclerosis
          1. Multiple sclerosis By Value
        6. Hashimoto's Thyroiditis
          1. Hashimoto's Thyroiditis By Value
        7. Idiopathic thrombocytopenic purpura
          1. Idiopathic thrombocytopenic purpura By Value
        8. Other Localized Autoimmune Diseases
          1. Other Localized Autoimmune Diseases By Value
    3. By Diagnosis
      1. Introduction
        1. Diagnosis By Value
      2. Antinuclear Antibody Tests
        1. By Value
      3. Autoantibody Tests
        1. By Value
      4. Complete Blood Count (CBC)
        1. By Value
      5. C-reactive Protein (CRP)
        1. By Value
      6. Urinalysis
        1. By Value
      7. Comprehensive Metabolic Panel
        1. By Value
      8. Erythrocyte Sedimentation Rate (ESR)
        1. By Value
      9. Other Tests
        1. By Value
    4. U.K.
      1. By Disease Type
        1. Introduction
          1. Disease Type By Value
        2. Systemic Autoimmune Disease
          1. By Value
          2. Rheumatoid Arthritis
            1. Rheumatoid Arthritis By Value
          3. Psoriasis
            1. Psoriasis By Value
          4. Systemic Lupus Erythematosus (SLE)
            1. Systemic Lupus Erythematosus (SLE) By Value
          5. Multiple Sclerosis
            1. Multiple Sclerosis By Value
          6. Ankylosing spondylitis
            1. Ankylosing spondylitis By Value
          7. Other Systemic Autoimmune Diseases
            1. Other Systemic Autoimmune Diseases By Value
        3. Localized Autoimmune Disease
          1. By Value
          2. Inflammatory Bowel Disease
            1. Inflammatory Bowel Disease By Value
          3. Type 1 Diabetes
            1. Type 1 Diabetes By Value
          4. Thyroid
            1. Thyroid By Value
          5. Multiple sclerosis
            1. Multiple sclerosis By Value
          6. Hashimoto's Thyroiditis
            1. Hashimoto's Thyroiditis By Value
          7. Idiopathic thrombocytopenic purpura
            1. Idiopathic thrombocytopenic purpura By Value
          8. Other Localized Autoimmune Diseases
            1. Other Localized Autoimmune Diseases By Value
      2. By Diagnosis
        1. Introduction
          1. Diagnosis By Value
        2. Antinuclear Antibody Tests
          1. By Value
        3. Autoantibody Tests
          1. By Value
        4. Complete Blood Count (CBC)
          1. By Value
        5. C-reactive Protein (CRP)
          1. By Value
        6. Urinalysis
          1. By Value
        7. Comprehensive Metabolic Panel
          1. By Value
        8. Erythrocyte Sedimentation Rate (ESR)
          1. By Value
        9. Other Tests
          1. By Value
    5. Germany
    6. France
    7. Spain
    8. Italy
    9. Russia
    10. Nordic
    11. Benelux
    12. Rest of Europ
    1. Europe Autoimmune Disease Diagnostics Market Share By Players
    2. M&A Agreements & Collaboration Analysis
    1. Siemens
      1. Overview
      2. Business Information
      3. Revenue
      4. ASP
      5. SWOT Analysis
      6. Recent Developments
    2. Grifols
    3. Trinity Biotech
    4. Werfen
    5. EUROIMMUN AG
    6. Oncimmune
    7. Seramun Diagnostica GmbH
    8. Cambridge Life Sciences Limited
    9. Menarini Diagnostics s.r.l
    10. ORGENTEC Diagnostika
    11. GROUP GMBH & CO. KG
    1. Research Data
      1. Secondary Data
        1. Major secondary sources
        2. Key data from secondary sources
      2. Primary Data
        1. Key data from primary sources
        2. Breakdown of primaries
      3. Secondary And Primary Research
        1. Key industry insights
    2. Market Size Estimation
      1. Bottom-Up Approach
      2. Top-Down Approach
      3. Market Projection
    3. Research Assumptions
      1. Assumptions
    4. Limitations
    5. Risk Assessment
    1. Discussion Guide
    2. Customization Options
    3. Related Reports
  3. Disclaimer

Related Reports

Global Report
Infectious Disease Diagnostics Market Size The global infectious disease diagnostics market size was valued at USD 22.85 billion in 2024 and is projected to reach from USD 24.65 billion in 2025 to USD 45.22 billion by 2033,
Buy Now
Global Report
Rare Disease Diagnostics Market Size The global rare disease diagnostics market size was valued at USD 1,152.35 million in 2024 and is projected to reach from USD 1,312.86 million in 2025 to USD 3,726.57 million by 2033, growing at a CAGR of 14.30%
Buy Now
Global Report
The global tissue diagnostics market size was worth USD 5,185.23 million in 2022. It is estimated to reach an expected value of USD 9,375.02 million by 2031, growing at a CAGR of 6.8% over the forecast period (2023–2031). Factors such as advanc
Buy Now

Purchase Benefits

  • Eligible for a free updated report next year
  • Completely customizable scope
  • 30% discount on your next purchase
  • Dedicated account manager
  • Query resolution within 24 hours
  • Permission to print the report

We are featured on :

ÀºÇòÅâÂÊ
© Copyright . All rights Reserved.